As solar energy plays an increasing role in the global power supply, ensuring accurate forecasts of photovoltaic (PV) power ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...

Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...

Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Artificial intelligence is reshaping the dairy supply chain, optimizing logistics and resource management while tackling ...

Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...

Utilising Machine Learning on clinical datasets could help to crack the enigma of feline infectious peritonitis diagnosis ...

To advance modern medicine, EPFL researchers are developing AI-based diagnostic tools. Their goal is to predict the best ...

Request To Download Free Sample of This Strategic Report @ Introduction: The genetic testing market in Vietnam has witnessed significant growth in recent years, fueled by advancements in technology, ...

Point-of-Care Testing (POCT): The proliferation of point-of-care testing devices is significantly enhancing diagnostic capabilities in Vietnam. These portable, user-friendly devices enable healthcare ...